Winston Pharmaceuticals, Inc.
WPHM · OTC
3/31/2010 | 12/31/2009 | 9/30/2009 | 6/30/2009 | |
|---|---|---|---|---|
| Market Cap | $6,967 | $5,102 | $5,102 | $4,990 |
| - Cash | $678 | $1,563 | $2,319 | $3,145 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $6,289 | $3,539 | $2,783 | $1,844 |
| Revenue | $317 | $339 | $351 | $365 |
| % Growth | -6.6% | -3.3% | -4% | – |
| Gross Profit | $317 | $339 | $351 | $365 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$459 | -$560 | -$701 | -$685 |
| % Margin | -145.1% | -165.2% | -199.9% | -187.8% |
| Net Income | -$461 | -$562 | -$702 | -$612 |
| % Margin | -145.5% | -165.7% | -200.4% | -167.7% |
| EPS Diluted | -0.01 | 0 | -0.01 | -0.01 |
| % Growth | – | 100% | 0% | – |
| Operating Cash Flow | -$883 | -$764 | -$826 | -$1,069 |
| Capital Expenditures | -$2 | -$0 | $0 | $0 |
| Free Cash Flow | -$885 | -$765 | -$826 | -$1,069 |